[ad_1]
A drug trial that saw pregnant women giving sildenafil was stopped after 11 babies died from drug-related complications.
As part of the scheme conducted by Amsterdam University Medical Center, pregnant women whose placentas were underdeveloped in the uterus. and had a high probability of preterm delivery took sildenafil.
Sildenafil is a treatment for erectile dysfunction in men that dilates blood vessels. The drug is also prescribed to treat high blood pressure.
The hope was that sildenafil would encourage blood flow to the placenta, subsequently promoting increased growth of the child – as supported by experimental research conducted on laboratory rats.
However, the trial, conducted in 10 hospitals in the Netherlands, was terminated when an independent committee discovered that more babies were dying after birth because of lung problems compared to babies born of women taking the placebo.
According to Marc van den Broek, a spokesperson for Amsterdam UMC who spoke to The Independent all women involved in the study had a "very low birth rate" and the children would be in intensive care after birth.
Of 93 women who received sildenafil in the trial, 17 babies developed lung problems, 11 of which have died since. In comparison, of the 90 women in a control group who took the placebo, only three developed the same lung problems. No babies succumbed to sildenafil-related conditions, but nine of them died of unrelated problems.
10-15 Other Women Still Waiting For Results On Their Children's Health After Trial